Related Experiment Videos
Genetics of amyotrophic lateral sclerosis
1Department of Neurology, Northwestern University Medical School, Chicago, IL 60611, USA.
Human Molecular Genetics
|January 1, 1996
Summary
Mutant copper-zinc superoxide dismutase (SOD1) causes amyotrophic lateral sclerosis (ALS) through a toxic gain of function. Protein misfolding and free radical generation are key to this neurodegenerative disease.
Area of Science:
- Neuroscience
- Genetics
- Biochemistry
Background:
- Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder characterized by motor neuron loss.
- Mutations in the copper-zinc superoxide dismutase (SOD1) gene are linked to familial ALS cases.
Purpose of the Study:
- To investigate the pathogenic mechanisms of mutant SOD1 in ALS.
- To understand the role of protein misfolding and free radical generation in ALS pathogenesis.
Main Methods:
- Development and utilization of a transgenic mouse model expressing mutant SOD1.
- Analysis of SOD1 protein conformation and its functional consequences.
Main Results:
- Mutant SOD1 exhibits a toxic gain of function, contributing to motor neuron degeneration.
- Evidence suggests free radical generation is involved in the disease process.
- Conformational changes in mutant SOD1, particularly in the electrostatic guidance channel, are implicated.
Conclusions:
- Mutant SOD1 plays a central role in ALS pathogenesis.
- Protein misfolding and subsequent toxic gain of function are critical mechanisms in ALS.
- Targeting mutant SOD1 or its downstream effects may offer therapeutic strategies for ALS.